0001878894-21-000003.txt : 20211004
0001878894-21-000003.hdr.sgml : 20211004
20211004162800
ACCESSION NUMBER: 0001878894-21-000003
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20211001
FILED AS OF DATE: 20211004
DATE AS OF CHANGE: 20211004
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: COLA MICHAEL F
CENTRAL INDEX KEY: 0001188940
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37590
FILM NUMBER: 211303149
MAIL ADDRESS:
STREET 1: 435 DEVON PARK BUILDING 800
CITY: WAYNE
STATE: PA
ZIP: 19087-1945
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Avalo Therapeutics, Inc.
CENTRAL INDEX KEY: 0001534120
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 450705648
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 540 GAITHER ROAD
STREET 2: SUITE 400
CITY: ROCKVILLE
STATE: MD
ZIP: 20850
BUSINESS PHONE: 410-522-8707
MAIL ADDRESS:
STREET 1: 540 GAITHER ROAD
STREET 2: SUITE 400
CITY: ROCKVILLE
STATE: MD
ZIP: 20850
FORMER COMPANY:
FORMER CONFORMED NAME: Cerecor Inc.
DATE OF NAME CHANGE: 20111102
4
1
edgar.xml
PRIMARY DOCUMENT
X0306
4
2021-10-01
0001534120
Avalo Therapeutics, Inc.
AVTX
0001188940
COLA MICHAEL F
C/O AVALO THERAPEUTICS, INC.
540 GAITHER ROAD, SUITE 400
ROCKVILLE
MD
20850
1
1
0
0
Chief Executive Officer
Stock Option (Right to Buy)
2.25
2021-10-01
4
A
0
78116
0
A
2021-10-01
2031-10-01
Common Stock
78116
78116
D
100% of this stock option will immediately vest on the date that it is granted. If employment is terminated prior to the end of the calendar quarter in which the option was granted, the number of shares underlying such stock
option that reflects the percentage of calendar days remaining in such calendar quarter after such employment termination date shall be forfeited and deemed cancelled.
/s/ Christopher R. Sullivan, by Power of Attorney
2021-10-04